Matthews Japan Fund Comments on Sysmex

Author's Avatar
Feb 05, 2015

Our holdings in the health care sector were leading contributors to performance in 2014. Long-term holding Sysmex (TSE:6869), a global leader in hematology equipment, performed well on the back of solid growth globally, particularly in China where growing household incomes are driving demand for health care services.

From Matthews Japan Fund (Trades, Portfolio) Q4 2014 Commentary.